✦ LIBER ✦

Temsirolimus enhances the growth inhibitory effect of trastuzumab in HER2-positive breast cancer cell lines

✍ Scribed by Elizabeth M.H. Kim; Hillary VanDusen; Catherine Lobocki

Book ID: 113680150
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 89 KB
Volume: 211
Category: Article
ISSN: 1072-7515
DOI: 10.1016/j.jamcollsurg.2010.06.321

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Growth inhibitory effects of trastuzumab

Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines

✍ Soo Jung Gong; Choon Jo Jin; Sun Young Rha; Hyun Cheol Chung 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 320 KB

Predicting for activity of second-line t

Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer

✍ Rupert Bartsch; Catharina De Vries; Ursula Pluschnig; Peter Dubsky; Zsuzsanna Ba 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 644 KB

Additive growth inhibitory effects of ib

Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines

✍ Fabrice Journe, Carole Chaboteaux, Nicolas Magne… 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 713 KB

Prenylated xanthones: antiproliferative

Prenylated xanthones: antiproliferative effects and enhancement of the growth inhibitory action of 4-hydroxytamoxifen in estrogen receptor-positive breast cancer cell line

✍ Ana Mafalda Paiva; Maria Emília Sousa; Ana Camões; Maria São José Nascimento; Ma 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 503 KB

415 Effect of herceptin on gene expressi

415 Effect of herceptin on gene expression in her2 positive breast cancer cell line

✍ C. McMonagle; R. Salman; V. Uhlmann; C. Curren 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Cost-effectiveness analysis of trastuzum

Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer

✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t